1. University Hospital of Salerno, 84100 Salerno, Italy 2. Department of Medicine, Surgery and Dentistry, University of Salerno, Fisciano, Italy;
Dr. Charlier graduated in Pharmaceutical Chemistry and Technology in 2008 at the University of Salerno. There, he obtained the postgraduate specialization in hospital pharmacy with honors in 2019 and a PhD in Translational Medicine in 2023. Dr. Charlier developed new azole-based molecular scaffolds for the synthesis and purification of non-steroidal inhibitors of the Aromatase enzyme (CYP19) while working on his thesis at the University of Salerno's Department of Pharmaceutical Sciences. He worked as a visiting scientist at the National Research Council's (CNR) Institute of Biomedicine and Molecular Immunology (IBIM) in Palermo in 2009. There, he developed knowledge in molecular biology techniques, such as gene sequencing, real-time PCR, and nucleic acid extraction, with an emphasis on the implementation of analytical protocols for the study of Anderson–Fabry disease. He worked as an analyst at the University Hospital's Molecular Biology Laboratory for Infectious Diseases in Salerno from 2010 to 2014. His work focuses on virological and genetic analysis and development of in-house protocols for real-time PCR and gene sequencing. From 2015 to 2020, Dr. Charlier oversaw the Clinical Pharmacology and Toxicology division of the “Biochemical s.r.l.” analysis laboratory in Salerno. Dr. Charlier started a collaboration with the Clinical Pharmacology Unit of the University Hospital of Salerno in 2015. His work focuses on the pharmacokinetics, pharmacodynamics, and bioaccumulation of drugs, as well as developing novel methods for pharmacologic and toxicologic applications. From 2023, he has been a pharmacist manager in the Clinical Pharmacology Unit.

Department of Medical Sciences, University of Turin, Italy;
Prof. D’Avolio is a clinical pharmacologist and Head of the Laboratory of Clinical Pharmacology and Pharmacogenetics at Amedeo di Savoia Hospital and ASL Città di Torino. His research focuses on the clinical pharmacology and pharmacogenetics of anti-infective agents, oncology drugs, monoclonal antibodies, antihypertensive therapies, and iron chelators, with particular emphasis on therapeutic drug monitoring, personalized medicine, and pharmacokinetic evaluation. He has extensive experience in translating pharmacogenetic findings into clinical practice and routinely oversees diagnostic analyses for therapeutic drug monitoring and genetic testing. Over the course of his career, he has collaborated with numerous national and international research centers, contributing to advances in clinical pharmacology and related diagnostics. Since 1994, he has delivered more than 400 presentations at scientific meetings, authored or co-authored over 400 international scientific publications, and achieved an H-index of 47 on Google Scholar and 41 on Scopus, reflecting his significant impact on the field.

Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University Chiang Mai, Thailand;
Associate Professor Baralee Punyawudho, Ph.D., currently serves in the Department of Pharmaceutical Care at the Faculty of Pharmacy, Chiang Mai University. She earned her B.Sc. in Pharmacy with Second Class Honors from Chulalongkorn University, Thailand and Ph.D. from the Department of Experimental and Clinical Pharmacology at the University of Minnesota, USA. Her research centers on dose optimization through population pharmacokinetics, especially of antiretroviral (ARV) agents. By integrating population pharmacokinetic modeling with patient covariates, including specific genetic polymorphisms, her work aims to systematically evaluate and redefine dosing strategies. The goal of this research is to establish evidence-based, optimized ARV regimens tailored to the unique physiological, pharmacokinetic, and genetic profiles of Thai and Asian populations, thereby maximizing therapeutic efficacy while minimizing toxicity. In recognition of her academic and professional excellence, Dr. Punyawudho was honored with The Nagai Award Thailand in 2018.